Kashyap TeleMed. (531960)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

Let me start with what the numbers allow as of now. Kashyap TeleMed has no sales in the latest quarter; sales growth is -100%. A business with zero revenue cannot be valued on earnings, so the P/E of 0.00 is not cheapness, it is absence. Book value per share is just ₹0.15, yet the market price is ₹2.42. That means I am being asked to pay 16.13 times stated book value for a company that earned a -28.88% return on equity. In plain language, every rupee of book value is melting away. The Piotroski F-Score of 2/9 tells me the financial condition is fragile. There is no dividend, no positive profit, and no visible revenue engine. The market capitalisation is only ₹12 Cr, and the price is below the stated 52-week range, which is a red flag rather than a bargain. Graham would say the margin of safety is absent: I am paying a large multiple of a tiny and deteriorating book value. This is not a franchise, there is no moat, and I cannot value a story with no numbers. IT-enabled services is a broad industry, but I don't invest in industries, I invest in businesses. The only way this becomes interesting is if there is true turnaround evidence: actual sales, positive margins, and a path to recover book value. Until then, this is an avoid. The price may look low in absolute rupees, but value is not measured by the price tag; it is measured by the cash flows and assets behind it. Here, both are missing.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer